- NEWS
New COVID drugs face delays as trials grow more difficult
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 606, 637 (2022)
doi: https://doi.org/10.1038/d41586-022-01602-5
References
Matrajt, L., Brown, E. R., Cohen, M. S., Dimitrov, D. & Janes, H. Preprint at medRxiv https://doi.org/10.1101/2021.11.10.21266139 (2022).
Beigel, J. H. et al. N. Engl. J. Med. 383,1813–1826 (2020).
Russell, J. A., Walley, K. R., Kalil, A. C. & Fowler, R. Ann. Amer. Thor. Soc. https://doi.org/10.1513/AnnalsATS.202203-250VP (2022).
Zhou, Y. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.06.06.494921 (2022).
Jochmans, D. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.06.07.495116 (2022).